Rakesh Jain

Rakesh Jain

Harvard University

H-index: 217

North America-United States

About Rakesh Jain

Rakesh Jain, With an exceptional h-index of 217 and a recent h-index of 120 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Inhibition of CXCR4 enhances the efficacy of radiotherapy in metastatic prostate cancer models

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular …

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

Rakesh Jain Information

University

Harvard University

Position

Massachusetts General Hospital, Harvard Medical School, Carnegie Mellon, Columbia, Delaware

Citations(all)

209662

Citations(since 2020)

61357

Cited By

173630

hIndex(all)

217

hIndex(since 2020)

120

i10Index(all)

532

i10Index(since 2020)

408

Email

University Profile Page

Harvard University

Top articles of Rakesh Jain

Title

Journal

Author(s)

Publication Date

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Cancer Immunology Research

Jiang Chen

Zohreh Amoozgar

Xin Liu

Shuichi Aoki

Zelong Liu

...

2024/2/20

Inhibition of CXCR4 enhances the efficacy of radiotherapy in metastatic prostate cancer models

Cancers

Nisha Gupta

Hiroki Ochiai

Yoshinori Hoshino

Sebastian Klein

Jozef Zustin

...

2023/2/6

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

Journal for ImmunoTherapy of Cancer

Xinyue Dong

Jun Ren

Zohreh Amoozgar

Somin Lee

Meenal Datta

...

2023

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Scientific Reports

Benjamin Wolf

Laura Weydandt

Nadja Dornhöfer

Grit Gesine Ruth Hiller

Anne Kathrin Höhn

...

2023/11/2

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

Proceedings of the National Academy of Sciences

Chrysovalantis Voutouri

C Corey Hardin

Vivek Naranbhai

Mohammad R Nikmaneshi

Melin J Khandekar

...

2023/1/17

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular …

Neuro-oncology

Scott R Plotkin

Jeffrey Allen

Girish Dhall

Jian L Campian

D Wade Clapp

...

2023/8/1

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Frontiers in immunology

J Bryan Iorgulescu

Neil Ruthen

Ryuhjin Ahn

Eleni Panagioti

Prafulla C Gokhale

...

2023/12/28

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

PLoS Computational Biology

Mohammad R Nikmaneshi

Rakesh K Jain

Lance L Munn

2023/6/8

Mathematical Model of Oxygen Transport in Tuberculosis Granulomas II: Transvascular and Interstitial Convection, Diffusion, and Reaction

Meenal Datta

McCarthy Kennedy

Laura E Via

James W Baish

Lei Xu

...

2023/1/11

Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma

Rakesh Jain

Shanmugarajan Krishnan

Somin Lee

Zohreh Amoozgar

Sonu Subudhi

...

2023/12/26

Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced …

Clinical Cancer Research

Yves Boucher

Jessica M Posada

Sonu Subudhi

Ashwin S Kumar

Spencer R Rosario

...

2023/4/14

Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy

Sonia A Patel

Monique B Nilsson

Xiuning Le

Tina Cascone

Rakesh K Jain

...

2023/1/4

Mathematical modeling of intratumoral immunotherapy yields strategies to improve the treatment outcomes

PLOS Computational Biology

Constantinos Harkos

Triantafyllos Stylianopoulos

Rakesh K Jain

2023/12/19

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models

Proceedings of the National Academy of Sciences

Meenal Datta

Sampurna Chatterjee

Elizabeth M Perez

Simon Gritsch

Sylvie Roberge

...

2023/2/7

Losartan rewires ovarian cancer tumor-immune microenvironment and suppresses IGF-1 to amplify chemo-immunotherapy sensitivity

bioRxiv

Yao Sun

Zhenzhen Yin

Limeng Wu

Changli Yue

Yanling Zhang

...

2023

Dissecting the Impact of the Gut Microbiome on Cancer Immunotherapy

Rakesh Jain

Andreas Hadjigeorgiou

Constantinos Harkos

Aditya Mishra

Golnaz Morad

...

2023/11/30

Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy

Journal of Controlled Release

Fotios Mpekris

Chrysovalantis Voutouri

Myrofora Panagi

James W Baish

Rakesh K Jain

...

2022/5/1

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors

CMAJ

Kieran L Quinn

Michael Fralick

Jonathan S Zipursky

Nathan M Stall

2020/5/19

Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells

bioRxiv

Zohreh Amoozgar

Jun Ren

Nancy Wang

Patrik Andersson

Gino B Ferraro

...

2022/9/4

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

Nature genetics

William L Hwang

Karthik A Jagadeesh

Jimmy A Guo

Hannah I Hoffman

Payman Yadollahpour

...

2022/8

See List of Professors in Rakesh Jain University(Harvard University)

Rakesh Jain FAQs

What is Rakesh Jain's h-index at Harvard University?

The h-index of Rakesh Jain has been 120 since 2020 and 217 in total.

What are Rakesh Jain's top articles?

The articles with the titles of

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Inhibition of CXCR4 enhances the efficacy of radiotherapy in metastatic prostate cancer models

Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular …

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization

...

are the top articles of Rakesh Jain at Harvard University.

What is Rakesh Jain's total number of citations?

Rakesh Jain has 209,662 citations in total.